It’s been a wild ride so far this year for shareholders of Sarepta Therapeutics Inc SRPT 2.71%. The year got off to a disastrous start back in January when the stock plummeted 55 percent in a single trading day after the FDA released advisory committee briefing documents that were highly critical of the company’s leading muscular dystrophy drug Eteplirsen.
The stock suffered another 66 percent plunge in April when the FDA advisory committee voted against recommending the drug for approval.
The stock quickly recovered much of its losses just days later when the FDA subsequently released a number of questions for Sarepta, including one about the effectiveness of Eteplirsen compared to historical data from boys suffering from Duchenne, but not included in the current trials.
On Wednesday, Sarepta’s announced that it has planned a $37 million public offering. Following the news, shares are trading up 10.9 percent in Thursday’s session.
Public Offerings In Store
Public offerings are usually seen as bad news for stocks, but PreMarket Prep’s Dennis Dick was not surprised by the positive market reaction.
“They’re doing an offering here, raising some cash,” Dick said on Thursday morning’s show. “They obviously think…
Click here to continue reading
Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common Sense. I don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!
